Publikace
- The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells2015 | Přírodovědecká fakulta, 2. lékařská fakulta
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | Přírodovědecká fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | Přírodovědecká fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | 2. lékařská fakulta
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | 2. lékařská fakulta
- Valproic Acid in the Complex Therapy of Malignant Tumors2010 | 2. lékařská fakulta
- Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment2023 | Přírodovědecká fakulta, 2. lékařská fakulta
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Přírodovědecká fakulta, 2. lékařská fakulta
- Miat is an upstream regulator of nmyc and the disruption of the miat/nmyc axis induces cell death in nmyc amplified neuroblastoma cell lines2021 | 2. lékařská fakulta
- Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model2021 | 2. lékařská fakulta
Loading network view...